COG — Cambridge Cognition Holdings Share News
0.000.00%
- £13.63m
- £13.63m
- £10.34m
REG - Cambridge Cognition - Board Appointment
AnnouncementREG - Cambridge Cognition - Launch of in-house rater training service
AnnouncementREG - Cambridge Cognition - Expanded partnership with Actinogen
AnnouncementRCS - Cambridge Cognition - CANTAB® success in Bristol Myers Squib research
AnnouncementREG - Cambridge Cognition - Director/PDMR Share Purchases
AnnouncementREG - Cambridge Cognition - Director/PDMR Share Purchases
AnnouncementREG - Cambridge Cognition - Director/PDMR Share Purchases
AnnouncementREG - Cambridge Cognition - Trading Update
AnnouncementREG - Cambridge Cognition - Holding(s) in Company
AnnouncementREG - Cambridge Cognition - Monument Therapeutics secures £1m investment
AnnouncementRCS - Cambridge Cognition - New data demonstrates effectiveness of AQUA
AnnouncementREG - Cambridge Cognition - Directorate Change
AnnouncementREG - Cambridge Cognition - Block Listing Return
AnnouncementREG - Cambridge Cognition - Directorate change
AnnouncementREG - Cambridge Cognition - Interim Results
AnnouncementREG - Cambridge Cognition - Notice of Results
AnnouncementREG - Cambridge Cognition - Holding(s) in Company
AnnouncementREG - AIM - AIM Notice - 31/07/2024
AnnouncementREG - Cambridge Cognition - Issue of Equity and Total Voting Rights
Announcement